A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.


Updates from The Motley Fool

Latest updates on Alexion Pharmaceuticals from Fool.com.  The Fool has written over 100 articles on Alexion Pharmaceuticals.


Stock Performance

View Interactive ALXN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Alexion Pharmaceuticals.
Current Price: $128.82
Prev Close: $130.39
Open: $130.00
Bid: $111.96
Ask: $128.97
Day's Range: $125.20 - $130.23
52wk Range: $109.12 - $162.00
Volume: 3,048,171
Avg Vol 2,311,469
Market Cap: $29B
P/E (ttm): 73.19
EPS (ttm): $1.76
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Alexion Pharmaceuticals.
CAPS Rating 3 out of 5
 
311 Outperform
57 Underperform
CAPS All Stars
 
78 Outperform
9 Underperform

How do you think Alexion Pharmaceuticals will perform against the market?



You pick for Alexion Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

David R. Brennan, CEO

72% Approve

Based on 8 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Alexion Pharmaceuticals.

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers